GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Question] API source — what am I missing here — 44 comments in the full submission. View in context.
1k
c/compounding·submitted 10 months ago by u/ignacio_vanhecke

[Question] API source — what am I missing here

Questionbranch of 8 comments

Right, the compounding question again, but with numbers this time. I have 21 data points over 12 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign. The thing I would flag for anyone new: the effect I am…

Read the full submission and all 44 comments →

This branch

8 comments, started 9 months ago
u/kavya_kravchenko107 points·9 months ago

503B compounding is different from 503A, different rules, different legality

replysharereportpermalink
u/ffmi_watcher78 points·9 months ago

Did they tell you their API source or dodge the question?

replysharereportpermalink
u/ignacio_vanheckeOP44 points·9 months ago

regulatory claims need a citation to the actual rule, not interpretation

replysharereportpermalink
u/controversial_only64 points·9 months ago

The confident tone is doing a lot of work that the evidence is not.

replysharereportpermalink
u/gallbladder_gary73 points·9 months ago

Not convinced. The evidence does not support that reading.

replysharereportpermalink
u/priya_palacios42 points·9 months ago·edited

Are we talking 503A or 503B?

replysharereportpermalink
u/medutest_mel50 points·9 months ago

telehealth prescriber models exist, pricing differs by state

replysharereportpermalink
load more comments (1) →

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/compounding
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/formulary_fighteru/usp_appendixu/quiet_moderatoru/prior_auth_pain
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →